Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Long-term immune checkpoint inhibition therapy for advanced stage Merkel cell carcinoma.
Journal: JAAD case reports
Published: January 09, 2026
A cytokine-based serum proteomic score is a prognostic biomarker for immunotherapy in head and neck cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: August 14, 2025
A genomic signature predictive of brain metastases in melanoma: Insights from the MSK-MET cohort.
Journal: Journal of the American Academy of Dermatology
Published: July 29, 2025
Depletion of conventional CD4+ T cells is required for robust priming and dissemination of tumor antigen-specific CD8+ T cells in the setting of anti-CD4 therapy.
Journal: Journal for immunotherapy of cancer
Published: October 15, 2024
Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma.
Journal: The British journal of dermatology
Published: July 30, 2024
Methylation cytometric pretreatment blood immune profiles with tumor mutation burden as prognostic indicators for survival outcomes in head and neck cancer patients on anti-PD-1 therapy.
Journal: NPJ precision oncology
Published: July 19, 2024
CD39 is expressed on functional effector and tissue resident memory CD8+ T cells.
Journal: bioRxiv : the preprint server for biology
Published: April 01, 2024
CD39 Is Expressed on Functional Effector and Tissue-resident Memory CD8+ T Cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 20, 2024
Association of Food Desert Residence and 5-Year Mortality in Lung Cancer Patients Undergoing Resection.
Journal: The Journal of surgical research
Published: March 04, 2024
Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series.
Journal: The American journal of case reports
Published: November 18, 2023
Rare immune-related adverse events in a patient with metastatic melanoma: a case report highlighting sarcoidosis-like reactions triggered by immune-checkpoint inhibitors.
Journal: Melanoma research
Published: October 13, 2023
Last Updated: 09/26/2026